Expenses : The company's expenses for the quarter were 1,137.90 crore, remaining relatively stable with a marginal 0.05% increase compared to the same quarter five years ago
More recently, Cornu et al
[98] [99] Novo Nordisk failed to pay a required patent maintenance fee, and their patent on the chemical structure of the drug expired in 2020
Other GLP-1 medications could follow suit for approvals, with a meta-analysis showing that GLP-1 agonists significantly reduced the risk of serious kidney complications in people with Type 2 diabetes
Ranked #1 by Forbes Health (2025), the app features Meal Scan photo logging, AI Coach, AI Restaurant Menu Scan, AI Voice logging, and a free Professional Connect platform for healthcare professionals
Paradoxically, activating the glucagon receptor in a controlled, pulsatile pharmacological fashion appears to increase energy expenditure, enhance fat burning in the liver, and promote thermogenesis, effects that purely GLP-1-based agents do not reliably produce